2003 Clinical Research Small Molecule Trials 
Drug Discovery World
OCTOBER 16, 2023
This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture. This is reflected by our recent share price performance outperforming the index in the past year.”
The Pharma Data
NOVEMBER 5, 2020
Prior to that, Taveras was vice president of Small Molecule Drug Discovery and CMC Development at Biogen Idec, and Alantos Pharmaceuticals, which was acquired by Amgen in 2007. Sussman has also had leadership experience in industry as the founder and vice president of both Amphioxus Cell Technologies from 1995 to 2003 and Hepatix, Inc.
Expert insights. Personalized for you.
189 
Let's personalize your content